Trading Summary - November 21. No change at open - 41M

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
167
Trading Summary - November 21.

No change at open - 41M on ask at .0005 - with suspect amount from NITE put up late.

No paint down attempts until closing minutes when balance of 11M whale buy order placed yesterday filled and another small 1.26M filled for somebody else.

Interestingly there remained a 10K bid from NITE at .0004 perhaps indicating that he is short of shares (probably borrowed for earlier shorting attempts) and that may account for any fake intimidation / blocking amount at .0005 trying to dupe others to sell needlessly for a loss.

The PR associated with the Q3 - that was filed on November 16 - has not been issued yet and it would now be better if it did not come out until Monday due to the Thanksgiving Holiday.

Until the PR comes out highlighting the excellent results - and hopefully also updating future brand expansion plans - only those who were looking for the Q3 - who mostly already have their shares - have seen it.

Stay sharp if you don't already have all the shares you need to make your profit expectations in 2017 and up to Q4 in March 2018. Prior warning and / or scanner alerts of any significant buys when the PR comes out will not be given on iHub.

Content below the line mainly unchanged from last update - relevant to those that are new here.

Only 15M has been picked up on the bid at .0003 in 13 weeks - all of it from insignificant paint downs in conjunction with associated bashing comments on iHub.

As previously stated, the large additional share retirement of 275M shares since Jul 31 - on top of the 150M retired Dec 2016 > May 2017 making 425M total - has not been PR'ed yet either.

For 13 weeks now, nobody has been duped by the fake stacked ask at .0005 or the nonsense from the non-credible bashers on iHub to sell for a loss at .0003. Two small paint downs today at .0003 - before the 10M+ ask slap - were of course ineffective as well.

Excellent update recently on the Verified Company Profile share structure at otcmarkets.com from the Transfer Agent (see new sticky #1902) - this has not been PR'ed yet to the wider investing community and has not been spotted by the inattentive on iHub:

O/S and A/S confirmed unchanged.

Float same as for all the runs this year - 50M reduction since Dec 2016.

Another 275M shares retired between Jul 31 and Oct 31 (as promised).

That takes total retired to 425M since May 31 - a significant reduction on such a small A/S and O/S for a stock in this price range.

There are at least 4 x whales who trade $DIGX continuously throughout each year who will be happy to take around 20M each if anyone is stupid or impatient enough to sell for a loss at any level below the current one. Any shares bought at .0004 will be worth an easy 150%+ profit on any of numerous runs likely to happen through to Q3 and Q4. Shares bought at .0005 should easily return 100%+ at some point in 2017 or 2018.

In my experience, 70M>100M is the optimum amount to take best advantage of each run whilst keeping the 25M cheapest batches for the bigger runs next year (especially Q4 in March 2018 when the full year profits will be up). My cheapest 25M retained for next year will not require any shares bought above .0004 now so all others will be tradeable for up to 100% during the remaining runs in 2017.

As expected, the status quo has been maintained throughout the inter Q2/Q3 PR period with it making little difference to long-term traders whether shares are picked up at .0004/5/6 - they will see a profit on all of them by Q3 / Q4 and on various runs between. The big boys in DIGX will probably be aiming to have an inventory of 50M>120M for trading through to end-2017 and in 2018.

Also expect further elements of the .0003 bidders - particularly those unlikely to fill on paint downs in the time remaining before the next run prior to / at Q3 - to continue to buy .0004s and .0005s whilst they are still available until they meet their desired holding. Only 50% of the bid at .0003 hitting the ask at .0005 would be sufficient to take out even the current fake ask if left there.

We can now look forward to additional updates on both the possible merger discussed recently and the implementation of the additional services being offered in the chiropractic chain offices - per the Strategic Growth Plan announced earlier - over the coming days, weeks and months..

The long whales will continue to buy at all prices that makes sense to them at any given point to have a cache for trading on any demand led run, the Q3 and through to the Annual Report in March 2018.

$DIGX will most likely not be allowed to go to previous year-end or inter-Q lows.

In my opinion, nobody has bought $DIGX in 2017 at a price that it isn't likely to exceed in the coming months (2017 high .0013) through to the Annual Report (March 2018).

Ludicrous claims by the notorious bashers currently on iHub - "RFB", "munimi", "Crown Capital" and "surfkast" - are clearly seen as such by all serious traders and now even by most short term (next Q) iHubbers.

Debunking nonsense posted by morons on iHub, there is absolutely no need or intention to do a reverse split. The share structure is exceptionally thin - with no dilution - and the company has been buying back shares. OTC market specialists who trade $DIGX continuously would not be loading 50M>100M shares at these inter-Q bottom prices to trade over the next 6 months if there was even the remote possibility of a reverse split.

Regardless of whether iHub posters lose interest over the coming days and weeks, detailed coverage will continue here as $DIGX remains one of my top picks for repeat profits for those that are patient and trade it to best effect (keep all cheapest batches of shares - create an inventory of shares at higher prices to trade on every run - big or small).

In addition, money is not considered "dead" by the most successful traders in the OTC market when they know it will provide a significant return further down the line because they are in a position to understand and influence - through keen observation and record keeping - what volume of shares is likely to be made available for purchase at any particular level.








American EcoFuels Inc (AEFI) Stock Research Links

AEFI Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

APP Group's New Conservation Efforts in Sumatra

Updated Category News Views 0

Taking a Bold Step Towards Conservation APP Group, in collaboration with Proforest, WWF-Indonesia, and KKI WARSI, is setting its sights on a more sustainable future with the PROTECT30 initiative. This isn't just another dime-a-dozen CSR project—it’s a concerted effort aimed at conserving Sumatra's precious Bukit Tigapuluh landscape. These folks are playing the long...

Continue Reading
Pen Needles Market to Hit $3.37B by 2031: Growth Ahead

Updated Category News Views 99

Big Numbers in the Needle Game When you're staring down the numbers popping out of this pen needles market projection, it's hard to ignore—shooting from a respectable $2.16 billion in 2026 to a hefty $3.37 billion by 2031. We're talking a 9.3% CAGR that'll have investors pulling out their calculators or maybe rubbing their hands in downright glee, depending on their...

Continue Reading
Maxwell M1 Hybrid Unveils Game-Changing Aircraft

Updated Category News Views 122

Welcome to the Future of Amphibious Flight You ever wonder when we'd get past seeing traditional planes stuck at runways? Well, Maxwell Aircraft just fired a hefty shot across the bow with their M1 Hybrid amphibious model. This ain't your run-of-the-mill crate with wings; it's redefining what these birds can do, particularly if you're eyeing remote areas or water-based...

Continue Reading
ANDPAD Shines in Asia's 2026 Growth Company Awards

Updated Category News Views 85

AI Takes Center Stage in Construction Ever seen AI shake a dusty old industry to its core? Well, if you haven't, ANDPAD is doing just that in construction, making waves across Asia. Look, when a company like ANDPAD snags a spot in the 'NextGen Tech 30 2026,' you pay attention. That's a glitzy award for the movers and shakers in tech, and these folks are doing some serious...

Continue Reading
Crunch Fitness Invests $5M in Jurupa Valley Expansion

Updated Category News Views 54

New Era for Crunch Fitness in Jurupa Valley When you've been around the block as much as some of us have, you learn to spot the makings of a solid investment. Fitness Ventures isn't just tossing another gym into the sea of treadmills and barbells; they're making waves with their new $5 million Crunch 3.0 club in Jurupa Valley. This isn't some half-baked, pop-up fitness...

Continue Reading
Teneo Expands Financial Advisory in Canada, Eyes Talent

Updated Category News Views 48

Turning the Maple Leaf Over: Teneo's Move Alright, here's the scoop: Teneo is muscling its way north, into Canada, to flex its Financial Advisory chops. With a lineup of 60 professionals already setting the pace across Toronto, Montreal, and Calgary, this move isn’t just smoke—it’s a full-fledged expansion. They're under the hood, tinkering away to beef up...

Continue Reading
Dr. Rod Rohrich Tops Facelift Surgeons Once Again

Updated Category News Views 57

A Consistent Top Performer in the Cosmetic Surgery World When the same name pops up as the best in their field year after year, it's not just luck—it's a testament to their skills and dedication. Newsweek has ranked Dr. Rod J. Rohrich as the top facelift surgeon in the U.S. for six consecutive years. Now that’s one heck of a streak in the cutthroat world of cosmetic...

Continue Reading
FX's Game-Changer: Stemless Reverse Shoulder System

Updated Category News Views 162

Stirring Up the Shoulder Market You gotta hand it to FX Shoulder Solutions – they've managed to elbow their way into the medical device market with something truly revolutionary. With the FDA clearance of Easytech Reversed®, a stemless reverse shoulder arthroplasty system, they're not just playing the innovation game; they're setting a whole new rulebook. This isn't...

Continue Reading
NextPlat Gears Up for Q3 2026 Earnings Call

Updated Category News Views 32

NextPlat's Upcoming Financial Revelation November is shaping up to be a month of revelations for NextPlat Corp (NASDAQ:NXPL) as they prepare to spill the beans on their third-quarter 2026 financials. The number crunching wraps up at 8:30 a.m. Eastern on November 12, when the execs will host an investor conference call. The Details of the Big Day Coming to you live from...

Continue Reading
Brian Long Exits Atlantic Bridge for US Tech Fund

Updated Category News Views 134

Well, here we go again with another shake-up in the tech investment world. Brian Long, a name that's been whispered around more than a few boardroom tables, is dropping out of Atlantic Bridge to start his own gig across the pond in the United States. If you're tracking numbers, Atlantic Bridge is juggling a healthy €1.4bn in assets—no small potatoes. So, let's dig...

Continue Reading

Top 5 Most Recently Viewed Articles

Discovering the Amazing Growth of Waste Management Stock

Updated Category News Views 150

Unveiling Waste Management's Financial Triumph Waste Management (NYSE: WM) has had a remarkable run over the past decade, consistently outperforming the broader market. With annual returns averaging 14.86%, investors have witnessed impressive growth as the company continues to thrive. The Impact of Compounding Returns The heart of investing often lies in the power of...

Continue Reading
Jasper Therapeutics Unveils Promising Briquilimab Findings

Updated Category News Views 332

Jasper Therapeutics Presents Briquilimab Data at AAAAI Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology firm known for its pioneering work, recently showcased updated findings from its clinical studies involving briquilimab, a groundbreaking antibody targeting c-Kit, aimed at treating mast cell driven diseases including chronic spontaneous urticaria (CSU) and...

Continue Reading
Cybersecurity Professionals to Command Salaries up to $270,000 in 2026

Updated Category News Views 509

Cybersecurity Salary Trends for 2026 As the demand for cybersecurity professionals continues to grow, the landscape of compensation is evolving rapidly. A recent analysis has revealed that salaries for high-clearance cybersecurity roles, particularly those requiring TS/SCI clearances with Full-Scope Polygraph, are projected to escalate significantly, reaching upwards of...

Continue Reading
Unlocking the Power of Apache Cassandra 5.0: A New Era of AI-Ready Databases

Updated Category News Views 70

Apache Software Foundation Launches Apache Cassandra 5.0 Today marks a significant milestone for database management as the Apache Software Foundation (ASF) announces the launch of Apache Cassandra 5.0. This version is set to redefine efficiency, security, and capability in handling large datasets. Revolutionary Features of Apache Cassandra 5.0 Apache Cassandra is...

Continue Reading
Discover the Thrilling History of Supercross in Pay Dirt

Updated Category News Views 496

Unveiling Supercross: The Narrative of Pay Dirt In a groundbreaking new film, Academy Award nominee Josh Brolin narrates the fascinating history of Supercross, a motorsport that began with a simple concept and evolved into a thrilling spectacle. The documentary, titled Pay Dirt: The Story of Supercross, brings to life the monumental tales surrounding this...

Continue Reading